A 22 year old male receiving carbamazepine for a bipolar affective dis
order presented with pyrexia, generalized rash, lymphadenopathy and he
patosplenomegaly. He was thrombocytopenic and liver function tests rev
ealed a hepatitic picture. Lymph node histology suggested a T-cell lym
phoma with many large cells possessing blastic features, and expressin
g CD3 and CD30 antigens, The abnormalities resolved completely within
nine weeks of discontinuing carbamazepine, indicating that the present
ing lymphadenopathy was secondary to lymphoid activation, ie; a pseudo
lymphoma rather than a malignant lymphoma, This is the first reported
case of carbamazepine-induced lymphadenopathy with CD30+ cells, It ill
ustrates the potential danger of relying too heavily on CD30 positivit
y as an indicator of malignancy.